The Design and Docking of Virtual Compound Libraries to Structures of Drug Targets

被引:25
作者
Anderson, Amy C. [1 ]
Wright, Dennis L. [1 ]
机构
[1] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Virtual screening; structure-based drug design; library design; drug discovery; diversity; filtering; ligand binding; docking;
D O I
10.2174/1573409052952279
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review provides a detailed analysis of the use of virtual library screening (VLS) in the drug discovery process. The first part is intended as a larger overview of the integrated VLS process. Small molecule and target macromolecule considerations will be described separately and will be subsequently integrated in a discussion of docking, scoring and evaluation. The second half of the review will focus on recent case studies that use VLS as part of an integrated drug discovery program. The case studies will illustrate the range of possible targets in VLS, provide an account of inclusive methodology and reveal the expectations for realistic goals. Recent efforts provide compelling evidence that VLS is successful when practiced in an integrated fashion involving synthetic, structural and computational expertise.
引用
收藏
页码:103 / 127
页数:25
相关论文
共 118 条
[11]  
BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/bf00124387
[12]   Discovery of a potent small molecule IL-2 inhibitor through fragment assembly [J].
Braisted, AC ;
Oslob, JD ;
Delano, WL ;
Hyde, J ;
McDowell, RS ;
Waal, N ;
Yu, C ;
Arkin, MR ;
Raimundo, BC .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (13) :3714-3715
[13]   Molecular recognition and docking algorithms [J].
Brooijmans, N ;
Kuntz, ID .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2003, 32 :335-373
[14]   A planning strategy for diversity-oriented synthesis [J].
Burke, MD ;
Schreiber, SL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2004, 43 (01) :46-58
[15]   MONTE-CARLO DOCKING OF OLIGOPEPTIDES TO PROTEINS [J].
CAFLISCH, A ;
NIEDERER, P ;
ANLIKER, M .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1992, 13 (03) :223-230
[16]   Developing a dynamic pharmacophore model for HIV-1 integrase [J].
Carlson, HA ;
Masukawa, KM ;
Rubins, K ;
Bushman, FD ;
Jorgensen, WL ;
Lins, RD ;
Briggs, JM ;
McCammon, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (11) :2100-2114
[17]   Protein flexibility and drug design: how to hit a moving target [J].
Carlson, HA .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :447-452
[18]   Structural studies on bioactive compounds.: 34.: Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase [J].
Chan, DCM ;
Laughton, CA ;
Queener, SF ;
Stevens, MFG .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (16) :2555-2564
[19]   Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins [J].
Charifson, PS ;
Corkery, JJ ;
Murcko, MA ;
Walters, WP .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (25) :5100-5109
[20]   FlexE: Efficient molecular docking considering protein structure variations [J].
Claussen, H ;
Buning, C ;
Rarey, M ;
Lengauer, T .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 308 (02) :377-395